These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 34621665)
1. Prognostic and Predicted Significance of FENDRR in Colon and Rectum Adenocarcinoma. Yang F; Sun S; Yang F Front Oncol; 2021; 11():668595. PubMed ID: 34621665 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma. Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464 [TBL] [Abstract][Full Text] [Related]
3. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
4. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
5. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
6. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
7. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma. Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450 [TBL] [Abstract][Full Text] [Related]
8. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma. Lin Y; Li Y; Chen Y; Zhang Z Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164 [TBL] [Abstract][Full Text] [Related]
9. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma]. Zhao H; Liu G; Li Y; Yang N; Zhao J Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647 [TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma. Pan S; Tang T; Wu Y; Zhang L; Song Z; Yu S Front Genet; 2021; 12():778153. PubMed ID: 35047006 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer. Dong X; Zhang Y; Sun Y; Nan Q; Li M; Ma L; Zhang L; Luo J; Qi Y; Miao Y BMC Med Genomics; 2023 Jun; 16(1):148. PubMed ID: 37370088 [TBL] [Abstract][Full Text] [Related]
12. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma. Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632 [TBL] [Abstract][Full Text] [Related]
13. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
14. A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients. Yang H; Lin HC; Liu H; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z Front Oncol; 2020; 10():81. PubMed ID: 32117736 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration. Kang M; Su Z Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36799193 [TBL] [Abstract][Full Text] [Related]
16. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD). Wang L; Cao Y; Guo W; Xu J J Cancer Res Clin Oncol; 2023 Jan; 149(1):15-24. PubMed ID: 36173462 [TBL] [Abstract][Full Text] [Related]
17. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912 [TBL] [Abstract][Full Text] [Related]
18. High expression levels of S1PR3 and PDGFRB indicates unfavorable clinical outcomes in colon adenocarcinoma. Yu M; Zhang K; Wang S Heliyon; 2024 Aug; 10(15):e35532. PubMed ID: 39170287 [TBL] [Abstract][Full Text] [Related]
19. Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma. Liang JZ; Liang XL; Zhong LY; Wu CT; Zhang J; Wang Y Front Oncol; 2020; 10():617890. PubMed ID: 33732636 [TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]